2025-11-17T14:49:45-06:00 2024-12-31 994625061 CRI ADVISORS LLC 7411 FULLERTON STREET SUITE 300 JACKSONVILLE FL 32256 990 2024-01-01 592624901 STOP CHILDREN'S CANCER INC STOP 3523772622 2622 NW 43RD STREET B3 GAINESVILLE FL 32606 LARRY HARTFIELD PRESIDENT 3523772622 2025-11-11 1 1 DANA ALEXANDER P01425283 9043566023 2025-11-11 2024 2025-03-06 01:10:19Z LARRY HARTFIELD 2622 NW 43RD STREET SUITE B3 GAINESVILLE FL 32606 1078420 0 X WWW.STOPCHILDRENSCANCER.ORG X 1981 FL THE MISSION OF STOP CHILDREN'S CANCER IS THE PREVENTION, CONTROL AND CURE OF CHILDHOOD CANCERS. FUNDS ARE RAISED ANNUALLY AND AWARDED TO SELECTED RESEARCH AGENCIES. 19 19 2 208 0 0 549651 354221 0 0 17344 106231 63256 56995 630251 517447 300000 200000 0 0 74361 81955 0 0 6097 122668 39976 497029 321931 133222 195516 1738879 1922828 1541 2055 1737338 1920773 X THE MISSION OF STOP CHILDREN'S CANCER IS THE PREVENTION, CONTROL AND CURE OF CHILDHOOD CANCERS. FUNDS ARE RAISED ANNUALLY AND AWARDED TO SELECTED RESEARCH AGENCIES. 0 0 285351 200000 SINCE ITS INCEPTION IN 1981, STOP CHILDREN'S CANCER HAS RAISED OVER $7 MILLION, INCLUDING THE BONNIE'S LEGACY ENDOWMENT FUND WHICH HAS APPROXIMATELY $1 MILLION IN PERPETUITY. IN ADDITION, AS A RESULT OF THESE DONATIONS, WELL IN EXCESS OF $18 MILLION IN NATIONAL CANCER INSTITUTE/NATIONAL INSTITUTE OF HEALTH (NIH) GRANTS AND OTHER AWARDS HAVE BEEN AWARDED.STOP CHILDREN'S CANCER / BONNIE R. FREEMAN CLINICAL TRIAL FUND:THIS FUND CONTINUES TO SUPPORT THE PROGRAM INFRASTRUCTURE, INCLUDING THE DIRECTOR'S POSITION WHO HAS LED OUR EFFORTS IN GROWING THE PEDIATRIC CANCER TRIALS. THIS INCLUDES ENROLLING 55 CHILDREN ON PEDIATRIC CANCER TREATMENT TRIALS, 84 PATIENTS ON BASIC SCIENCE, SUPPORTIVE CARE, OR SURVIVORSHIP STUDIES, AND AN ADDITIONAL 64 ENROLLED ON THE CHILDREN'S ONCOLOGY GROUP REGISTRY AND BIOLOGY STUDY DURING THE ACADEMIC YEAR. STOP CHILDREN'S CANCER / KIMBERLY H. FLAITZ RESEARCH GRANT:A KEY GOAL OF THIS RESEARCH FUND WAS TO SUPPORT WORK ON DEVELOPING VACCINES FOR PEDIATRIC OSTEOSARCOMA WITH THE ULTIMATE GOAL OF OPENING A TRIAL USING ONE OF THESE TECHNOLOGIES IN CHILDREN. THE FUNDING CONTINUED TO SUPPORT THE SALARY OF DR. MATTHEW CASCIO WORKING ON DEVELOPING LIPID-NANOPARTICLE(NP) VACCINES AND CAR T CELL IMMUNOTHERAPY. IN PARTNERSHIP WITH DRS. CASCIO AND MILNER (MENTOR), WE HAVE ESTABLISHED A JOINT PEDIATRIC AND LARGE-ANIMAL CANCER IMMUNOTHERAPY PROGRAM. TOGETHER WE HAVE MANUFACTURED CLINICAL GRADE LIPID-NANOPARTICLE VACCINES. IN PET-DOGS WITH SPONTANEOUSLY OCCURRING OSA, WE HAVE SHOWN THAT LIPID-NP VACCINES ELICIT IMMUNE RESPONSES WITH IMPROVING THE DOGS' LONG-TERM SURVIVAL.LYRICS FOR LIFE / STOP CHILDREN'S CANCER JEFFREY A. BLOCK RESEARCH GRANT:THIS FUNDING SUPPORTED DR. PAUL CASTILLO, WHO IS WORKING ON DEVELOPING NOVEL IMMUNOTHERAPIES TO TREAT REFRACTORY CANCERS, ESPECIALLY T-CELL LEUKEMIAS AND T-CELL LYMPHOMAS. GIVEN THE STRIKING RESULTS OF A COMBINATIONAL APPROACH USING CAR T CELLS AND RNA NANOPARTICLE-BASED VACCINES, HE CONTINUES HIS WORK USING THIS APPROACH THAT WAS REPORTED IN 2021. HE HAS SHOWN PROMISING DATA USING THIS IMMUNOTHERAPEUTIC COMBINATIONAL APPROACH FOR ACUTE MYELOID LEUKEMIA, METASTATIC OSTEOSARCOMA, AND METASTATIC MELANOMA. THE PROMISE OF THIS APPROACH IS THAT IT CONTINUES TO HOLD ANTICANCER EFFICACY FOR A WIDE RANGE OF CANCERS. THIS FUNDING ALSO SUPPORTED A REVIEW PAPER THAT WAS PUBLISHED, DESCRIBING TUMOR MODELS FOR EVALUATION OF CAR T CELLS. 285351 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 4 0 1 2 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 19 19 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 FL X TRACY CHRISTIE 3523772622 2622 NW 43RD STREET SUITE B3 GAINESVILLE FL 32606 X PHYLLIS BAUCOM SECRETARY 1.00 X X 0 0 0 LYNN BENNETT BOARD MEMBER 1.00 X 0 0 0 JIM BRANDENBURG VICE PRESIDENT 1.00 X X 0 0 0 BECKY DE MARIE BOARD MEMBER 1.00 X 0 0 0 PAT DOOLEY BOARD MEMBER 1.00 X 0 0 0 BETH FLAITZ BOARD MEMBER 1.00 X 0 0 0 CAROLYNE R FREEMAN BOARD MEMBER 1.00 X 0 0 0 HOWARD FREEMAN BOARD MEMBER 1.00 X 0 0 0 LAUREL FREEMAN BOARD MEMBER 1.00 X 0 0 0 JAY HUTTO BOARD MEMBER 1.00 X 0 0 0 MAC MCCARTY BOARD MEMBER 1.00 X 0 0 0 STORM ROBERTS BOARD MEMBER 1.00 X 0 0 0 JAMES ROBERTSON PRESIDENT 1.00 X X 0 0 0 CINDY SMYDER TREASURER 1.00 X X 0 0 0 MARY ANNE WESTPHAL BOARD MEMBER 1.00 X 0 0 0 LARRY HARTFIELD VICE PRESIDENT 1.00 X X 0 0 0 JIM CARNES BOARD MEMBER 1.00 X 0 0 0 MARC SPIWAK BOARD MEMBER 1.00 X 0 0 0 JAMES QUESENBERRY BOARD MEMBER 1.00 X 0 0 0 0 0 0 0 0 0 0 0 288904 65317 91343 354221 59261 59261 468309 421339 46970 46970 46970 196629 288904 139634 56995 56995 517447 0 0 163226 200000 200000 76076 53253 19019 3804 5879 4115 1470 294 5273 3691 1318 264 6024 4217 1506 301 100 70 25 5 6621 4635 1655 331 537 376 134 27 3111 2177 778 156 5604 3923 1401 280 3204 2243 801 160 DUES & SUBSCRIPTIONS 9488 6642 2372 474 MISCELLANEOUS 14 9 4 1 321931 285351 30483 6097 214122 322480 159014 66519 98100 92495 1426657 1507853 1738879 1922828 1541 2055 1541 2055 X 1737338 1920773 1737338 1920773 1738879 1922828 195516 -12081 0 X 0 0 0 X 245286 211431 381819 549651 354221 1742408 245286 211431 381819 549651 354221 1742408 27214 1715194 36326 39355 34863 42281 106232 259057 196630 196630 2198095 0.78030 0.84180 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 140000 54250 85750 19014 12269 6745 92495 BEAR 158302 35200 123102 110 4838 GOLF CLASSIC 145781 125114 20667 21236 18704 21016 2459 5 181450 128590 52860 4749 10192 34956 5250 16124 485533 288904 196629 25985 28896 56082 5250 23421 139634 56995 1 UNIVERISITY OF FLORIDA FOUNDATION PO BOX 14425 GAINESVILLE FL 32604 590974739 501(C)(3) 200000 0 TO FUND SALARY IN THE PEDIATRIC CLINICAL TRIAL PROGRAMS AND FUND RESEARCH OF CHILDHOOD CANCERS AT THE UNIVERSITY OF FLORIDA. 1 1 PART I, LINE 2: BOARD OF DIRECTORS RECEIVES SCHEDULED PROGRESS REPORTS WITH REGARD TO THE RESEARCH FUNDED BY THE GRANT. X 5 25446 FAIR MARKET VALUE X OTHER 6 65897 FAIR MARKET VALUE 0 1 0 FORM 990, PART VI, SECTION A, LINE 2 HOWARD FREEMAN - DIRECTOR AND LAUREL FREEMAN - DIRECTOR ARE SPOUSES CAROLYNE FREEMAN - DIRECTOR IS THE DAUGHTER OF LAUREL FREEMAN - DIRECTOR CAROLYNE FREEMAN - DIRECTOR IS THE DAUGHTER OF HOWARD FREEMAN - DIRECTOR FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE 990 IS PROVIDED TO THE PRESIDENT AND TREASURER PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY BY REQUIRING ANY DIRECTOR TO DISCLOSE IF THERE IS A CONFLICT PRIOR TO VOTING ON ANY GIVEN ISSUE. FORM 990, PART VI, SECTION B, LINE 15 WHEN NECESSARY, THE EXECUTIVE COMMITTEE APPOINTS A REVIEW COMMITTEE TO REVIEW COMPENSATION PACKAGES. THE REVIEW COMMITTEE WILL THEN BRING BACK FINDINGS TO THE EXECUTIVE COMMITTEE FOR DISCUSSION. AFTER THIS REVIEW, THE COMPENSATION PACKAGES WOULD BE BROUGHT TO THE FULL BOARD TO BE VOTED ON AND APPROVED. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.